Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Aspira Women's Health Inc. (AWH : NSDQ)
 
 • Company Description   
Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas.

Number of Employees: 108

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.45 Daily Weekly Monthly
20 Day Moving Average: 574,554 shares
Shares Outstanding: 112.21 (millions)
Market Capitalization: $50.62 (millions)
Beta: 2.88
52 Week High: $6.25
52 Week Low: $0.32
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -55.78% -51.72%
12 Week -56.63% -53.12%
Year To Date -74.51% -69.81%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12117 BEE CAVES ROAD BUILDING THREE SUITE 100
-
AUSTIN,TX 78738
USA
ph: 512-519-0400
fax: 512-439-6908
arr@lifesciadvisors.com http://www.aspirawh.com
 
 • General Corporate Information   
Officers
Nicole Sandford - Chief Executive Officer and President
Valerie B. Palmieri - Executive Chair of the Board of Directors and Dire
Robert Beechey - Chief Financial Officer
James T. LaFrance - Director
Celeste Fralick - Director

Peer Information
Aspira Women's Health Inc. (ABMD)
Aspira Women's Health Inc. (DMDS)
Aspira Women's Health Inc. (CPWY.)
Aspira Women's Health Inc. (EQUR)
Aspira Women's Health Inc. (ECIA)
Aspira Women's Health Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 04537Y109
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 112.21
Most Recent Split Date: (:1)
Beta: 2.88
Market Capitalization: $50.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.33 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.33
Price/Cash Flow: -
Price / Sales: 7.02
EPS Growth
vs. Year Ago Period: -60.00%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 26.54%
vs. Previous Quarter: 2.27%
ROE
03/31/22 - -102.03
12/31/21 - -75.46
09/30/21 - -78.11
ROA
03/31/22 - -79.65
12/31/21 - -61.11
09/30/21 - -61.97
Current Ratio
03/31/22 - 4.85
12/31/21 - 5.10
09/30/21 - 7.36
Quick Ratio
03/31/22 - 4.82
12/31/21 - 5.08
09/30/21 - 7.34
Operating Margin
03/31/22 - -485.64
12/31/21 - -464.80
09/30/21 - -449.23
Net Margin
03/31/22 - -485.64
12/31/21 - -464.80
09/30/21 - -449.23
Pre-Tax Margin
03/31/22 - -485.64
12/31/21 - -464.80
09/30/21 - -449.23
Book Value
03/31/22 - 0.19
12/31/21 - 0.27
09/30/21 - 0.34
Inventory Turnover
03/31/22 - 25.22
12/31/21 - 31.06
09/30/21 - 48.71
Debt-to-Equity
03/31/22 - 0.12
12/31/21 - 0.09
09/30/21 - 0.07
Debt-to-Capital
03/31/22 - 10.85
12/31/21 - 8.26
09/30/21 - 6.71
 

Powered by Zacks Investment Research ©